{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:22:12Z","timestamp":1791638532291,"version":"4.3.4"},"reference-count":49,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,31]],"date-time":"2018-03-31T00:00:00Z","timestamp":1522454400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lipidjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.jacl.2018.03.093","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T13:32:55Z","timestamp":1522848775000},"page":"920-927.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":158,"title":["Clinical and biochemical features of different molecular etiologies of familial chylomicronemia"],"prefix":"10.1016","volume":"12","author":[{"given":"Robert A.","family":"Hegele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda J.","family":"Berberich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Ban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Digenio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica J.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"D'Erasmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3786-0883","authenticated-orcid":false,"given":"Marcello","family":"Arca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Bruckert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik S.","family":"Stroes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Bergeron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7043-0952","authenticated-orcid":false,"given":"Fernando","family":"Civeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph L.","family":"Witztum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Gaudet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2018.03.093_bib1","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1194\/jlr.R009720","article-title":"Genetic determinants of plasma triglycerides","volume":"52","author":"Johansen","year":"2011","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2018.03.093_bib2","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1503\/cmaj.060963","article-title":"Hypertriglyceridemia: its etiology, effects and treatment","volume":"176","author":"Yuan","year":"2007","journal-title":"CMAJ"},{"key":"10.1016\/j.jacl.2018.03.093_bib3","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ymgme.2007.10.007","article-title":"Monogenic pediatric dyslipidemias: classification, genetics and clinical spectrum","volume":"93","author":"Rahalkar","year":"2008","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.jacl.2018.03.093_bib4","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nrg2481","article-title":"Plasma lipoproteins: genetic influences and clinical implications","volume":"10","author":"Hegele","year":"2009","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.jacl.2018.03.093_bib5","doi-asserted-by":"crossref","first-page":"981","DOI":"10.3390\/nu5030981","article-title":"Hypertriglyceridemia","volume":"5","author":"Brahm","year":"2013","journal-title":"Nutrients"},{"key":"10.1016\/j.jacl.2018.03.093_bib6","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nrendo.2015.26","article-title":"Chylomicronaemia\u2013current diagnosis and future therapies","volume":"11","author":"Brahm","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jacl.2018.03.093_bib7","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1194\/jlr.M031195","article-title":"Structural and functional analysis of APOA5 mutations identified in patients with severe hypertriglyceridemia","volume":"54","author":"Mendoza-Barbera","year":"2013","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2018.03.093_bib8","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1056\/NEJMoa1400284","article-title":"Targeting APOC3 in the familial chylomicronemia syndrome","volume":"371","author":"Gaudet","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2018.03.093_bib9","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1056\/NEJMoa1400283","article-title":"Antisense inhibition of apolipoprotein C-III in patients with hypertriglyceridemia","volume":"373","author":"Gaudet","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2018.03.093_bib10","doi-asserted-by":"crossref","first-page":"e96482","DOI":"10.1371\/journal.pone.0096482","article-title":"Post-heparin LPL activity measurement using VLDL as a substrate: a new robust method for routine assessment of plasma triglyceride lipolysis defects","volume":"9","author":"Di Filippo","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jacl.2018.03.093_bib11","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.atherosclerosis.2017.07.030","article-title":"Alterations in plasma triglycerides lipolysis in patients with history of multifactorial chylomicronemia","volume":"265","author":"Marmontel","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2018.03.093_bib12","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1194\/jlr.D045963","article-title":"LipidSeq: a next-generation clinical resequencing panel for monogenic dyslipidemias","volume":"55","author":"Johansen","year":"2014","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2018.03.093_bib13","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/MOL.0000000000000163","article-title":"Targeted next-generation sequencing in monogenic dyslipidemias","volume":"26","author":"Hegele","year":"2015","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jacl.2018.03.093_bib14","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1093\/nar\/gkq603","article-title":"ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data","volume":"38","author":"Wang","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jacl.2018.03.093_bib15","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1038\/nprot.2015.105","article-title":"Genomic variant annotation and prioritization with ANNOVAR and wANNOVAR","volume":"10","author":"Yang","year":"2015","journal-title":"Nat Protoc"},{"key":"10.1016\/j.jacl.2018.03.093_bib16","article-title":"HMDB 3.0\u2013The Human Metabolome Database in 2013","volume":"41","author":"Wishart","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jacl.2018.03.093_bib17","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkn810","article-title":"HMDB: a knowledgebase for the human metabolome","volume":"37","author":"Wishart","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jacl.2018.03.093_bib18","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkl923","article-title":"HMDB: the human metabolome database","volume":"35","author":"Wishart","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jacl.2018.03.093_bib19","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature15393","article-title":"A global reference for human genetic variation","volume":"526","author":"Auton","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jacl.2018.03.093_bib20","series-title":"Exome Variant Server, NHLBI GO Exome Sequencing Project (ESP)","year":"2017"},{"key":"10.1016\/j.jacl.2018.03.093_bib21","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nature19057","article-title":"Analysis of protein-coding genetic variation in 60,706 humans","volume":"536","author":"Lek","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jacl.2018.03.093_bib22","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","article-title":"A method and server for predicting damaging missense mutations","volume":"7","author":"Adzhubei","year":"2010","journal-title":"Nat Methods"},{"key":"10.1016\/j.jacl.2018.03.093_bib23","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/nprot.2009.86","article-title":"Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm","volume":"4","author":"Kumar","year":"2009","journal-title":"Nat Protoc"},{"key":"10.1016\/j.jacl.2018.03.093_bib24","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1093\/nar\/gkg509","article-title":"SIFT: Predicting amino acid changes that affect protein function","volume":"31","author":"Ng","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jacl.2018.03.093_bib25","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/ng.2892","article-title":"A general framework for estimating the relative pathogenicity of human genetic variants","volume":"46","author":"Kircher","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.jacl.2018.03.093_bib26","doi-asserted-by":"crossref","first-page":"1254806","DOI":"10.1126\/science.1254806","article-title":"RNA splicing. The human splicing code reveals new insights into the genetic determinants of disease","volume":"347","author":"Xiong","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.jacl.2018.03.093_bib27","first-page":"557","article-title":"Prediction of mutant mRNA splice isoforms by information theory-based exon definition","volume":"34","author":"Mucaki","year":"2013","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jacl.2018.03.093_bib28","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12944-017-0488-4","article-title":"Genetic determinants of inherited susceptibility to hypercholesterolemia - a comprehensive literature review","volume":"16","author":"Paththinige","year":"2017","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.jacl.2018.03.093_bib29","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1056\/NEJM199106203242502","article-title":"A mutation in the human lipoprotein lipase gene as the most common cause of familial chylomicronemia in French Canadians","volume":"324","author":"Ma","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2018.03.093_bib30","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1001\/jamainternmed.2013.13309","article-title":"Severe hypertriglyceridemia with pancreatitis: thirteen years' treatment with lomitapide","volume":"174","author":"Sacks","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacl.2018.03.093_bib31","doi-asserted-by":"crossref","first-page":"5910","DOI":"10.1016\/S0021-9258(19)39449-9","article-title":"Missense mutation (Gly\u2013Glu188) of human lipoprotein lipase imparting functional deficiency","volume":"265","author":"Emi","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jacl.2018.03.093_bib32","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jacl.2017.03.015","article-title":"Extreme hypertriglyceridemia, pseudohyponatremia, and pseudoacidosis in a neonate with lipoprotein lipase deficiency due to segmental uniparental disomy","volume":"11","author":"Ashraf","year":"2017","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2018.03.093_bib33","doi-asserted-by":"crossref","first-page":"F514","DOI":"10.1136\/archdischild-2014-305940","article-title":"A neonate with a 'milky' blood. What can it be?","volume":"99","author":"Bordugo","year":"2014","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.jacl.2018.03.093_bib34","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/0888-7543(92)90136-G","article-title":"A missense mutation (Asp250\u2013Asn) in exon 6 of the human lipoprotein lipase gene causes chylomicronemia in patients of different ancestries","volume":"13","author":"Ma","year":"1992","journal-title":"Genomics"},{"key":"10.1016\/j.jacl.2018.03.093_bib35","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1034\/j.1399-0004.2000.570209.x","article-title":"Pseudodominance of lipoprotein lipase (LPL) deficiency due to a nonsense mutation (Tyr302>Term) in exon 6 of LPL gene in an Italian family from Sardinia (LPL(Olbia))","volume":"57","author":"Bertolini","year":"2000","journal-title":"Clin Genet"},{"key":"10.1016\/j.jacl.2018.03.093_bib36","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1172\/JCI115229","article-title":"Amino acid substitution (Ile194\u2013--Thr) in exon 5 of the lipoprotein lipase gene causes lipoprotein lipase deficiency in three unrelated probands. Support for a multicentric origin","volume":"87","author":"Henderson","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacl.2018.03.093_bib37","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1161\/ATVBAHA.111.238493","article-title":"Apolipoprotein B-100-containing lipoprotein metabolism in subjects with lipoprotein lipase gene mutations","volume":"32","author":"Ooi","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2018.03.093_bib38","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/BF00212035","article-title":"Homozygosity for a mutation in the lipoprotein lipase gene (Gly139-->Ser) causes chylomicronaemia in a boy of Spanish descent","volume":"93","author":"Bijvoet","year":"1994","journal-title":"Hum Genet"},{"key":"10.1016\/j.jacl.2018.03.093_bib39","first-page":"1275","article-title":"A missense mutation (Trp86\u2013--Arg) in exon 3 of the lipoprotein lipase gene: a cause of familial chylomicronemia","volume":"50","author":"Ishimura-Oka","year":"1992","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jacl.2018.03.093_bib40","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-2796.2012.02516.x","article-title":"Mutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients with severe hypertriglyceridaemia","volume":"272","author":"Surendran","year":"2012","journal-title":"J Intern Med"},{"key":"10.1016\/j.jacl.2018.03.093_bib41","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1172\/JCI115507","article-title":"Heterogeneous mutations in the human lipoprotein lipase gene in patients with familial lipoprotein lipase deficiency","volume":"88","author":"Gotoda","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacl.2018.03.093_bib42","first-page":"53","article-title":"Severe hypertriglyceridemia in an infant of Arab descent","volume":"15","author":"Behar","year":"2013","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.jacl.2018.03.093_bib43","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/(SICI)1098-1004(1997)10:6<465::AID-HUMU8>3.0.CO;2-C","article-title":"Familial lipoprotein lipase (LPL) deficiency: a catalogue of LPL gene mutations identified in 20 patients from the UK, Sweden, and Italy","volume":"10","author":"Mailly","year":"1997","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jacl.2018.03.093_bib44","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.atherosclerosis.2015.04.815","article-title":"Spectrum of mutations of the LPL gene identified in Italy in patients with severe hypertriglyceridemia","volume":"241","author":"Rabacchi","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2018.03.093_bib45","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/S0022-2275(20)41340-9","article-title":"Molecular basis of familial chylomicronemia: mutations in the lipoprotein lipase and apolipoprotein C-II genes","volume":"33","author":"Reina","year":"1992","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2018.03.093_bib46","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.atherosclerosissup.2012.10.020","article-title":"A three month-old infant with severe hyperchylomicronemia: molecular diagnosis and extracorporeal treatment","volume":"14","author":"Stefanutti","year":"2013","journal-title":"Atheroscler Suppl"},{"key":"10.1016\/j.jacl.2018.03.093_bib47","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0022-2275(20)41188-5","article-title":"A compound heterozygote for lipoprotein lipase deficiency, Val69-->Leu and Gly188-->Glu: correlation between in\u00a0vitro LPL activity and clinical expression","volume":"35","author":"Bruin","year":"1994","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2018.03.093_bib48","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/j.cca.2011.08.001","article-title":"Two novel rare variants of APOA5 gene found in subjects with severe hypertriglyceridemia","volume":"412","author":"Pisciotta","year":"2011","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jacl.2018.03.093_bib49","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.atherosclerosis.2014.02.005","article-title":"Type 1 hyperlipoproteinemia due to a novel deletion of exons 3 and 4 in the GPIHBP1 gene","volume":"234","author":"Berge","year":"2014","journal-title":"Atherosclerosis"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287418301983?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287418301983?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T22:06:35Z","timestamp":1660773995000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287418301983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S1933287418301983"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2018.03.093","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and biochemical features of different molecular etiologies of familial chylomicronemia","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2018.03.093","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc. on behalf of National Lipid Association.","name":"copyright","label":"Copyright"}]}}